Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-22-006435
Filing Date
2022-04-29
Accepted
2022-04-29 12:36:42
Documents
15
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A gdnsf-20211231x10ka.htm   iXBRL 10-K/A 406658
2 EX-31.1 gdnsf-20211231xex31d1.htm EX-31.1 6083
3 EX-31.2 gdnsf-20211231xex31d2.htm EX-31.2 6177
  Complete submission text file 0001558370-22-006435.txt   742036

Data Files

Seq Description Document Type Size
4 EX-101.SCH gdnsf-20211231.xsd EX-101.SCH 5159
5 EX-101.DEF gdnsf-20211231_def.xml EX-101.DEF 49093
6 EX-101.LAB gdnsf-20211231_lab.xml EX-101.LAB 31377
7 EX-101.PRE gdnsf-20211231_pre.xml EX-101.PRE 21379
9 EXTRACTED XBRL INSTANCE DOCUMENT gdnsf-20211231x10ka_htm.xml XML 12288
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Goodness Growth Holdings, Inc. (Filer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-56225 | Film No.: 22872620
SIC: 2834 Pharmaceutical Preparations